New 340B provider reporting requirements were included in recently proposed legislation from a Connecticut state health agency, as part of [...] …
Articles by : William Newton, Associate Editor/Senior Writer
A key committee in the Oregon state house could vote tomorrow on a bill that would prohibit drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
One influential Republican senator criticized 340B and another Republican senator expressed support for the program during today’s much-awaited Senate committee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland lawmakers in the state house and senate have introduced companion bills that would prohibit drugmaker 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Major hospital groups last week urged the U.S. Supreme Court to review a federal appeals court decision that upheld how [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri state senators in recent weeks have introduced three bills with provisions to bar pharmacy benefit managers (PBMs) from what 340B providers describe as underpayments and other discriminatory practices.
On Jan. 3, Missouri state Sens. Curtis Trent (R) and Doug
…
A federal district judge last week denied two community health centers’ antitrust claims against four major diabetes drug manufacturers over [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eight Mississippi state senators have introduced a bill to bar drugmakers from restricting 340B contract pharmacy use and pharmacy benefit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California hospital last week reached a settlement to pay the state of California and the U.S. government a combined [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...] …